Cornea/External Disease News

With the exception of the eventual, however begrudging, acceptance of dry eye disease as a thing, the biggest paradigm shift in the dry eye world has been the acknowledgement that both tear quality and quantity matter.

Aramis Biosciences has launched following the completion of Series A financing totaling $10.5 million, according to a press release.

NEW ORLEANS — A retrospective study in patients undergoing penetrating keratoplasty combined with temporary keratoprosthesis and vitreoretinal surgery identified silicone oil and history of trauma as risk factors for graft failure.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Penny Asbell, MD, FACS, MBA, discusses results from the ARMOR study and the implications of selecting the correct antibiotic to combat endophthalmitis.

The lifestyle changes brought by the COVID-19 pandemic have caused a dramatic increase in the incidence and severity of dry eye disease, or DED.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Eric D. Donnenfeld, MD, discusses the benefits and applications of corneal cross-linking in patients with keratoconus.

A study conducted on tissue samples and cultured cells demonstrated that SARS-CoV-2 can efficiently infect human conjunctival epithelial cells, eliciting innate immune response.

NEW ORLEANS — Children younger than 14 years of age who had partial-thickness corneal pathologies benefited long term from deep anterior lamellar keratoplasty, according to a presentation.

OTX-DED met the primary endpoint in a phase 2 trial investigating the ophthalmic insert for safety and efficacy in the short-term treatment of dry eye disease, according to a press release from Ocular Therapeutix.

The ocular surface extends from the conjunctiva to the cornea, including the fornices and the inner surfaces of the lids.